10 likes | 102 Views
This study delves into the location and cellular IC50 values of Bcr-Abl GNF-2 resistance mutations for potential therapeutic implications, as published in Nature. The research sheds light on mechanisms of drug resistance in cancer treatment.
E N D
Location and cellular IC50 of Bcr–Abl GNF-2 resistance mutations. JM Zhang et al.Nature000, 1-6 (2010) doi:10.1038/nature08675